"Designing Growth Strategies is in our DNA"

Orphan Drugs Market Size, Share & COVID-19 Impact Analysis, By Therapy Area (Oncology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, and Others), By Drug Type (Biologics, and Non-Biologics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, and Others), and Regional Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI100088

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of major orphan disease, by key countries
    2. Pipeline review for orphan drugs
    3. Technological Developments
    4. Healthcare spending for key countries – 2019
  5. Global Orphan Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy Area
      1. Oncology
      2. Hematology
      3. Neurology
      4. Endocrinology
      5. Cardiovascular
      6. Respiratory
      7. Immunotherapy
      8. Others
    3. Market Analysis, Insights and Forecast – By Drug Type
      1. Biologics
      2. Non-Biologics
    4. Market Analysis, Insights and Forecast – By Distribution Channels
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Sales
      4. Others
    5. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Orphan Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy Area
      1. Oncology
      2. Hematology
      3. Neurology
      4. Endocrinology
      5. Cardiovascular
      6. Respiratory
      7. Immunotherapy
      8. Others
    3. Market Analysis, Insights and Forecast – By Drug Type
      1. Biologics
      2. Non-Biologics
    4. Market Analysis, Insights and Forecast – By Distribution Channels
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Sales
      4. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Orphan Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy Area
      1. Oncology
      2. Hematology
      3. Neurology
      4. Endocrinology
      5. Cardiovascular
      6. Respiratory
      7. Immunotherapy
      8. Others
    3. Market Analysis, Insights and Forecast – By Drug Type
      1. Biologics
      2. Non-Biologics
    4. Market Analysis, Insights and Forecast – By Distribution Channels
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Sales
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Orphan Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy Area
      1. Oncology
      2. Hematology
      3. Neurology
      4. Endocrinology
      5. Cardiovascular
      6. Respiratory
      7. Immunotherapy
      8. Others
    3. Market Analysis, Insights and Forecast – By Drug Type
      1. Biologics
      2. Non-Biologics
    4. Market Analysis, Insights and Forecast – By Distribution Channels
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Sales
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Orphan Drugs Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapy Area
      1. Oncology
      2. Hematology
      3. Neurology
      4. Endocrinology
      5. Cardiovascular
      6. Respiratory
      7. Immunotherapy
      8. Others
    3. Market Analysis, Insights and Forecast – By Drug Type
      1. Biologics
      2. Non-Biologics
    4. Market Analysis, Insights and Forecast – By Distribution Channels
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Sales
      4. Others
  10. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Company Profiles
      1. Johnson & Johnson
      2. Alexion Pharmaceuticals Inc
      3. Amgen Inc
      4. F. Hoffmann-La Roche Ltd.,
      5. AstraZeneca plc.
      6. Bayer AG
      7. GlaxoSmithKline plc.
      8. Shire plc.
      9. Eisai Co. Ltd.
      10. Others
  11. Strategic Recommendations
Read Less

Figure 1:  Global Orphan Drugs Market Revenue Breakdown (US$ Bn, %) by Region, 2019 & 2027

Figure 2:  Global Orphan Drugs Market Value Share (%), by Therapy Area, 2019 & 2027

Figure 3:  Global Orphan Drugs Market Forecast (US$ Bn), by Oncology, 2016-2027

Figure 4:  Global Orphan Drugs Market Forecast (US$ Bn), by Hematology, 2016-2027

Figure 5:  Global Orphan Drugs Market Forecast (US$ Bn), by Neurology, 2016-2027

Figure 6:  Global Orphan Drugs Market Forecast (US$ Bn), by Endocrinology, 2016-2027

Figure 7:  Global Orphan Drugs Market Forecast (US$ Bn), by Cardiovascular, 2016-2027

Figure 8:  Global Orphan Drugs Market Forecast (US$ Bn), by Respiratory, 2016-2027

Figure 9:  Global Orphan Drugs Market Forecast (US$ Bn), by Immunotherapy, 2016-2027

Figure 10:  Global Orphan Drugs Market Forecast (US$ Bn), by Others, 2016-2027

Figure 11:  Global Orphan Drugs Market Value Share (%), by Drug Type, 2019 & 2027

Figure 12:  Global Orphan Drugs Market Forecast (US$ Bn), by Biologics, 2016-2027

Figure 13:  Global Orphan Drugs Market Forecast (US$ Bn), by Non-Biologics, 2016-2027

Figure 14:  Global Orphan Drugs Market Value Share (%), by Distribution Channels, 2019 & 2027

Figure 15:  Global Orphan Drugs Market Forecast (US$ Bn), by Hospital Pharmacy, 2016-2027

Figure 16:  Global Orphan Drugs Market Forecast (US$ Bn), by Retail Pharmacy, 2016-2027

Figure 17:  Global Orphan Drugs Market Forecast (US$ Bn), by Online Sales, 2016-2027

Figure 18:  Global Orphan Drugs Market Forecast (US$ Bn), by Others, 2016-2027

Figure 19:  Global Orphan Drugs Market Value (US$ Bn), by Region, 2019 & 2027

Figure 20:  North America Orphan Drugs Market Value (US$ Bn), by Therapy Area, 2019 & 2027

Figure 21:  North America Orphan Drugs Market Value Share (%), by Therapy Area, 2019

Figure 22:  North America Orphan Drugs Market Value (US$ Bn), by Drug Type, 2019 & 2027

Figure 23:  North America Orphan Drugs Market Value Share (%), by Drug Type, 2019

Figure 24:  North America Orphan Drugs Market Value (US$ Bn), by Distribution Channels, 2019 & 2027

Figure 25:  North America Orphan Drugs Market Value Share (%), by Distribution Channels, 2019

Figure 26:  North America Orphan Drugs Market Value (US$ Bn), By Country, 2019 & 2027

Figure 27:  North America Orphan Drugs Market Value Share (%), By Country, 2019

Figure 28:  Europe Orphan Drugs Market Value (US$ Bn), by Therapy Area, 2019 & 2027

Figure 29:  Europe Orphan Drugs Market Value Share (%), by Therapy Area, 2019

Figure 30:  Europe Orphan Drugs Market Value (US$ Bn), by Drug Type, 2019 & 2027

Figure 31:  Europe Orphan Drugs Market Value Share (%), by Drug Type, 2019

Figure 32:  Europe Orphan Drugs Market Value (US$ Bn), by Distribution Channels, 2019 & 2027

Figure 33:  Europe Orphan Drugs Market Value Share (%), by Distribution Channels, 2019

Figure 34:  Europe Orphan Drugs Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 35:  Europe Orphan Drugs Market Value Share (%), By Country/ Sub-region, 2019

Figure 36:  Asia Pacific Orphan Drugs Market Value (US$ Bn), by Therapy Area, 2019 & 2027

Figure 37:  Asia Pacific Orphan Drugs Market Value Share (%), by Therapy Area, 2019

Figure 38:  Asia Pacific Orphan Drugs Market Value (US$ Bn), by Drug Type, 2019 & 2027

Figure 39:  Asia Pacific Orphan Drugs Market Value Share (%), by Drug Type, 2019

Figure 40:  Asia Pacific Orphan Drugs Market Value (US$ Bn), by Distribution Channels, 2019 & 2027

Figure 41:  Asia Pacific Orphan Drugs Market Value Share (%), by Distribution Channels, 2019

Figure 42:  Asia Pacific Orphan Drugs Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 43:  Asia Pacific Orphan Drugs Market Value Share (%), By Country/ Sub-region, 2019

Figure 44:  Rest of the World Orphan Drugs Market Value (US$ Bn), by Therapy Area, 2019 & 2027

Figure 45:  Rest of the World Orphan Drugs Market Value Share (%), by Therapy Area, 2019

Figure 46:  Rest of the World Orphan Drugs Market Value (US$ Bn), by Drug Type, 2019 & 2027

Figure 47:  Rest of the World Orphan Drugs Market Value Share (%), by Drug Type, 2019

Figure 48:  Rest of the World Orphan Drugs Market Value (US$ Bn), by Distribution Channels, 2019 & 2027

Figure 49:  Rest of the World Orphan Drugs Market Value Share (%), by Distribution Channels, 2019

Figure 50:  Global Orphan Drugs Market Share (%), By Company, 2019

Table 1:  Global Orphan Drugs Market Revenue (US$ Bn) Forecast, by Therapy Area, 2016–2027

Table 2:  Global Orphan Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2016–2027

Table 3:  Global Orphan Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channels, 2016–2027

Table 4:  Global Orphan Drugs Market Revenue (US$ Bn) Forecast, by Region, 2016-2027

Table 5:  North America Orphan Drugs Market Revenue (US$ Bn) Forecast, by Therapy Area, 2016-2027

Table 6:  North America Orphan Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2016-2027

Table 7:  North America Orphan Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channels, 2016-2027

Table 8:  North America Orphan Drugs Market Revenue (US$ Bn) Forecast, By Country, 2016-2027

Table 9:  Europe Orphan Drugs Market Revenue (US$ Bn) Forecast, by Therapy Area, 2016-2027

Table 10:  Europe Orphan Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2016-2027

Table 11:  Europe Orphan Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channels, 2016-2027

Table 12:  Europe Orphan Drugs Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 13:  Asia Pacific Orphan Drugs Market Revenue (US$ Bn) Forecast, by Therapy Area, 2016-2027

Table 14:  Asia Pacific Orphan Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2016-2027

Table 15:  Asia Pacific Orphan Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channels, 2016-2027

Table 16:  Asia Pacific Orphan Drugs Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 17:  Rest of the World Orphan Drugs Market Revenue (US$ Bn) Forecast, by Therapy Area, 2016-2027

Table 18:  Rest of the World Orphan Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2016-2027

Table 19:  Rest of the World Orphan Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channels, 2016-2027

Booklet
  • Aug, 2020
  • 2019
  • 2016-2018
  • 135

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Compare Licenses Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X